A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast CancerAutumn J. McRee, Elizabeth Claire Dees, Dominic T. Moore et al.|Clinical Breast Cancer|2017Cited by 30